Catalyst Oncology

A media release issued last Wednesday from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and based on data presented at the recent annual meeting of the American Society for Clinical Oncology (ASCO), is suggesting that it is possible to predict, with greater accuracy, the long-term risk of metastatic disease in men treated surgically for supposedly localized prostate cancer.The data on which this media release is based were presented at the ASCO meeting by Antonarakis et al., a

See original here:
Risk for metastasis post-surgery: a prognostic algorithm